A cancer drug’s first broad safety update is set for Oct. 14 from Verastem
A cancer drug’s first broad safety update is set for Oct. 14 from Verastem Stock Titan
Онкология
🎗️Лента новостей
Онкология
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center Yahoo! Finance Canada
🎗️
Онкология
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment Healthcare Brew
Онкология
First global patient recruited for rare blood cancer study at King’s
First global patient recruited for rare blood cancer study at King’s Clinical Trials Arena
Онкология
BrainChild Bio raises over $100 million to treat kids’ cancers with CAR-Ts
BrainChild Bio raises over $100 million to treat kids’ cancers with CAR-Ts C&EN
Онкология
Research at Cincinnati Children’s Makes Impact in the Quest to Defeat Childhood Cancer
Research at Cincinnati Children’s Makes Impact in the Quest to Defeat Childhood Cancer Research Horizons
Онкология
Milestones: going to school after cancer - Cancer Research UK
Milestones: going to school after cancer Cancer Research UK - Cancer News
Онкология
Children with cancer are being saved, but are we breaking them in the process?
Survival rates for childhood cancer now exceed 80%—but this also means more children are living with the long-term emotional and psychosocial impacts of cancer.
Онкология
В Институте онкологии не хватает препарата для лечения рака. Гаснаш объяснил причину и пообещал «изменить правила игры
В Институте онкологии не хватает препарата для лечения рака. Гаснаш объяснил причину и пообещал «изменить правила игры newsmaker.md
Онкология
Scientists find a new weakness in treatment-resistant prostate cancer
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity. Combining two types of drugs reversed many of these changes and sharply slowed tumor growth in preclinical experiments, offering a possible new strategy for aggressive, treatment-resistant…
Онкология
Germany’s NRW state bets €200M on AI-powered cancer research
Germany’s NRW state bets €200M on AI-powered cancer research European Biotechnology Magazine
Онкология
Не таблетки, а тренировки: британские учёные нашли способ смягчить последствия лечения рака
Не таблетки, а тренировки: британские учёные нашли способ смягчить последствия лечения рака Правда.Ру
Онкология
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure
PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure PA Media
Онкология
Ученые нашли новый способ лечения острого миелоидного лейкоза
Ученые нашли новый способ лечения острого миелоидного лейкоза Наука Mail
Онкология
Сможет ли искусственный интеллект найти лекарство от рака?
Сможет ли искусственный интеллект найти лекарство от рака? vietnam.vn